BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10220743)

  • 1. Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha 1 adrenoceptor antagonist administration on anesthetized portal hypertensive rats.
    Huang YT; Lin LC; Chern JW; Lin HC; Hong CY
    Liver; 1999 Apr; 19(2):129-34. PubMed ID: 10220743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
    Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
    Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.
    Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY
    Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal hypotensive effects of DL-028 and prazosin on portal hypertensive rats.
    Huang YT; Lin LC; Chern JW; Lin HC; Hong CY
    Pharmacology; 1998 Sep; 57(3):132-8. PubMed ID: 9691233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
    Moreau R; Cailmail S; Valla D; Lebrec D
    Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
    Heinemann A; Stauber RE
    J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
    Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
    J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
    Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
    PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
    Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD
    Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension.
    Huang YT; Wu HL; Chern JW; Lin HC; Hong CY
    Scand J Gastroenterol; 1998 Dec; 33(12):1303-9. PubMed ID: 9930395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
    Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats.
    Chang FC; Huang YT; Hong CY; Lin JG; Chen KJ
    Eur J Gastroenterol Hepatol; 1999 Sep; 11(9):1027-31. PubMed ID: 10503841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
    Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
    Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
    Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
    J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of synephrine treatment in portal hypertensive rats.
    Huang YT; Lin HC; Chang YY; Yang YY; Lee SD; Hong CY
    Jpn J Pharmacol; 2001 Feb; 85(2):183-8. PubMed ID: 11286401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.
    Lee FY; Wang SS; Tsai MH; Huang HC; Lin HC; Lee SD
    PLoS One; 2014; 9(3):e92093. PubMed ID: 24633079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.